Skip to main content
. 2022 Oct 3;1:100055. doi: 10.1016/j.dialog.2022.100055

Table 1.

Distribution and prevalence of HPV genotypes among the female and male patients in the study.

HPV Genotype No. (%) Total patients No. (%) Female patients no. (%) Male patients
16 11 (3.4%) 10 (3.6%) 1 (2.3%)
18 5 (1.6%) 4 (1.5%) 1 (2.3%)
31 2 (0.6%) 1 (0.4%) 1 (2.3%)
35 1 (0.3%) 0 (0.0%) 1 (2.3%)
39 5 (1.6%) 5 (1.8%) 0 (0.0%)
45 2 (0.6%) 2 (0.7%) 0 (0.0%)
51 2 (0.6%) 2 (0.7%) 0 (0.0%)
52 3 (0.9%) 3 (1.1%) 0 (0.0%)
56 3 (0.9%) 3 (1.1%) 0 (0.0%)
58 2 (0.6%) 2 (0.7%) 0 (0.0%)
59 1 (0.3%) 1 (0.4%) 0 (0.0%)
68 2 (0.6%) 2 (0.7%) 0 (0.0%)
53 9 (2.8%) 5 (1.8%) 4 (9.1%)
66 2 (0.6%) 2 (0.7%) 0 (0.0%)
67 4 (1.3%) 2 (0.7%) 2 (4.5%)
70 1 (0.3%) 1 (0.4%) 0 (0.0%)
73 3 (0.9%) 3 (1.1%) 0 (0.0%)
82 7 (2.2%) 6 (2.2%) 1 (2.3%)
6 23 (7.2%) 12 (4.3%) 11 (25%)
11 12 (3.8%) 10 (3.6%) 2 (4.5%)
41 1 (0.3%) 0 (0.0%) 1 (2.3%)
42 2 (0.6%) 1 (0.4%) 1 (2.3%)
44 1 (0.3%) 1 (0.4%) 0 (0.0%)
54 6 (1.9%) 5 (1.8%) 1 (2.3%)
61 2 (0.6%) 2 (0.7%) 0 (0.0%)
62 2 (0.6%) 2 (0.7%) 0 (0.0%)
81 3 (0.9%) 2 (0.7%) 1 (2.3%)
84 2 (0.6%) 2 (0.7%) 0 (0.0%)
87 4 (1.3%) 2 (0.7%) 2 (4.5%)